Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Pathways reviewed by Cuadrado, Antonio (9761944)

DB_ID Name
9762114 GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2
8951664 Neddylation
9759194 Nuclear events mediated by NFE2L2
9755511 KEAP1-NFE2L2 pathway

Details on Person Cuadrado, Antonio

Class:IdPerson:9761944
_displayNameCuadrado, Antonio
_timestamp2022-04-22 15:30:40
affiliation[Affiliation:9768344] Autonomous University of Madrid, Spain, Chair of COST Action CA20121 on “Bench to bedside transition for pharmacological regulation of NRF2 in noncommunicable diseases (BenBedPhar)” Department of Biochemistry Faculty of Medicine
created[InstanceEdit:9761945] Rothfels, Karen, 2022-01-17
crossReference[DatabaseIdentifier:9772512] ORCID:0000-0002-4039-7140
firstnameAntonio
initialA
modified[InstanceEdit:9768345] Rothfels, Karen, 2022-03-07
[InstanceEdit:9772513] D'Eustachio, Peter, 2022-04-22
surnameCuadrado
(author)[InstanceEdit:9766992] Cuadrado, Antonio, 2022-02-23
[LiteratureReference:9761948] Glycogen synthase kinase-3beta inhibits the xenobiotic and antioxidant cell response by direct phosphorylation and nuclear exclusion of the transcription factor Nrf2
[LiteratureReference:9761972] Nrf2 is controlled by two distinct β-TrCP recognition motifs in its Neh6 domain, one of which can be modulated by GSK-3 activity
[LiteratureReference:9761989] Regulation of heme oxygenase-1 expression through the phosphatidylinositol 3-kinase/Akt pathway and the Nrf2 transcription factor in response to the antioxidant phytochemical carnosol
[LiteratureReference:9761995] SCF/{beta}-TrCP promotes glycogen synthase kinase 3-dependent degradation of the Nrf2 transcription factor in a Keap1-independent manner
[LiteratureReference:9762004] Signaling pathways activated by the phytochemical nordihydroguaiaretic acid contribute to a Keap1-independent regulation of Nrf2 stability: Role of glycogen synthase kinase-3
[LiteratureReference:9762014] Structural and functional characterization of Nrf2 degradation by the glycogen synthase kinase 3/β-TrCP axis
[LiteratureReference:9766099] Structural and functional characterization of Nrf2 degradation by glycogen synthase kinase 3/β-TrCP
[LiteratureReference:9766101] Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases
[LiteratureReference:9766110] Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach
(replacementInstances)[_Deleted:9772514] Deletion of instance: 9761974
[Change default viewing format]